CN206027207U - Coronary heart disease treatment filter - Google Patents

Coronary heart disease treatment filter Download PDF

Info

Publication number
CN206027207U
CN206027207U CN201620625224.6U CN201620625224U CN206027207U CN 206027207 U CN206027207 U CN 206027207U CN 201620625224 U CN201620625224 U CN 201620625224U CN 206027207 U CN206027207 U CN 206027207U
Authority
CN
China
Prior art keywords
carbon film
layer
heart disease
coronary heart
blood
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201620625224.6U
Other languages
Chinese (zh)
Inventor
黄鹤平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yixing Bernard Investment Co Ltd
Original Assignee
Jiangsu Bofa Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Bofa Biotechnology Co Ltd filed Critical Jiangsu Bofa Biotechnology Co Ltd
Priority to CN201620625224.6U priority Critical patent/CN206027207U/en
Application granted granted Critical
Publication of CN206027207U publication Critical patent/CN206027207U/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • External Artificial Organs (AREA)

Abstract

The utility model relates to a coronary heart disease treatment filter, it includes the casing the casing top is equipped with blood inlet and gas vent respectively the casing bottom is equipped with blood and exports be equipped with the filter layer in the casing, is the filter layer 0.35 from the last three -layer aperture that down includes 0.55 mu m's carbon film and the poly(ether sulfone) filtration membrane that the one deck aperture is 0.2 mu m, the thickness of three -layer carbon film is the same, and the thickness of every layer of carbon film is 5mm, and is individual layer carbon film and poly(ether sulfone) filtration membrane's thickness than being (7 10 ): 1. The utility model discloses a blood extracorporal circulatory system effectively reduces the blood consistency.

Description

Coronary heart disease treatment filter
Technical field
This utility model is related to a kind of medical apparatus and instruments, and in particular to a kind of coronary heart disease defecator.
Background technology
Coronary heart disease is clinically common frequently-occurring disease, and modern medicine thinks that coronary heart disease is due to coronary atherosclerosiies Or thrombosis are attached on coronary blood tube wall and cause coronary stricture, are reduced by blood flow coronarius, when Cardiac load increases suddenly, needs blood volume to increase, and has exceeded the compensatory capacity of coronary artery blood supply, or has needed blood volume not increase, but is preced with Shape spasm, reduce blood flow, or above-mentioned factor be present simultaneously, can all cause palpitate quickly, ischemia, anoxia and occur Angina pectoriss.Both at home and abroad the method for the treatment of coronary heart disease is various, the formation and thrombosis including coronary artery dilator and anti-tampon it is poly- Collection, but the curative effect of these methods is unstable, the easy recurrent exerbation of the state of an illness.
The content of the invention
Goal of the invention:The purpose of this utility model is to overcome deficiency of the prior art, there is provided a kind of patient passes through Blood extracorporeal circulation, effectively reduces the coronary heart disease treatment filter of blood viscosity.
Technical scheme:In order to solve above-mentioned technical problem, coronary heart disease treatment filter described in the utility model, it includes Housing, is respectively equipped with blood entry port and air vent in the case top, is provided with blood outlet in the housing bottom, described Filter layer is provided with housing, and the filter layer is from top to bottom including the carbon film and one layer of aperture that three layers of aperture are 0.35-0.55 μm For 0.2 μm of polyethersulfone filter film, the thickness of three layers of carbon film is identical, and the thickness of every layer of carbon film is 5mm, monolayer carbon film and polyether sulfone The thickness ratio of filter membrane is(7-10):1.
The thickness of the polyethersulfone filter film is 0.5 mm.
A diameter of 100 mm of the housing.
The housing is divided into lid and lower cover, and they are integral type structure.
Beneficial effect:Compared with prior art, its remarkable advantage is this utility model:The letter of this utility model overall structure It is single, it is using integral structure, easy to process, it is high in machining efficiency, adopt thickness ratio for(7-10):1 aperture is 0.35-0.55 μm Carbon film and polyethersulfone filter film that aperture is 0.2 μm, and carbon film arranges three layers, patient by blood extracorporeal circulation, effectively Blood viscosity and the other harmful substances matter in blood is reduced, so as to effectively treatment coronary heart disease, meets actual operation requirements.
Description of the drawings
Fig. 1 is structural representation of the present utility model.
Specific embodiment
With reference to the accompanying drawings and examples this utility model is further described.
As shown in figure 1, coronary heart disease treatment filter described in the utility model, it includes housing 1, pushes up in the housing 1 Portion is respectively equipped with blood entry port 2 and air vent 3, is provided with blood outlet 4 in 1 bottom of the housing, is provided with the housing 1 Filtering layer, the filter layer from top to bottom including three layers of aperture for 0.35-0.55 μm carbon film 5 and one layer of aperture be 0.2 μm poly- Ether sulfone filter membrane 6, the thickness of three layers of carbon film 5 are identical, and the thickness of every layer of carbon film 5 is 5mm, monolayer carbon film 5 and polyethersulfone filter film 6 Thickness ratio be(7-10):1;The thickness of the polyethersulfone filter film 6 is 0.5 mm;A diameter of 100 mm of the housing 1;Institute It is upper lid 7 and lower cover 8 to state 1 point of housing, and they are integral type structure.This utility model overall structure is simple, is tied using integral type Structure, it is easy to process, it is high in machining efficiency, adopt thickness ratio for(7-10):1 aperture for 0.35-0.55 μm carbon film and aperture be 0.2 μm of polyethersulfone filter film, and carbon film arranges three layers, and patient effectively reduces blood viscosity by blood extracorporeal circulation Other harmful substances matter with blood, so as to effectively treatment coronary heart disease, meets actual operation requirements.
This utility model provides a kind of thinking and method, and the method and approach for implementing the technical scheme is a lot, with Only it is preferred implementation of the present utility model described in upper, it is noted that for those skilled in the art, On the premise of without departing from this utility model principle, some improvements and modifications can also be made, these improvements and modifications should also be regarded For protection domain of the present utility model, in the present embodiment, clearly each ingredient not can use prior art to be realized.

Claims (4)

1. coronary heart disease treatment filter, it is characterised in that:It includes housing(1), in the housing(1)Top is respectively equipped with blood Entrance(2)And air vent(3), in the housing(1)Bottom is provided with blood outlet(4), in the housing(1)Filtration is provided with inside Layer, the filter layer is from top to bottom including the carbon film that three layers of aperture are 0.35-0.55 μm(5)It is 0.2 μm poly- with one layer of aperture Ether sulfone filter membrane(6), three layers of carbon film(5)Thickness it is identical, every layer of carbon film(5)Thickness be 5mm, monolayer carbon film(5)And polyethers Sulfone filter membrane(6)Thickness ratio be(7-10):1.
2. coronary heart disease treatment filter according to claim 1, it is characterised in that:The polyethersulfone filter film(6)Thickness For 0.5 mm.
3. coronary heart disease treatment filter according to claim 1, it is characterised in that:The housing(1)A diameter of 100 mm.
4. coronary heart disease treatment filter according to claim 1, it is characterised in that:The housing(1)It is divided into lid(7)With under Lid(8), they are integral type structure.
CN201620625224.6U 2016-06-23 2016-06-23 Coronary heart disease treatment filter Expired - Fee Related CN206027207U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201620625224.6U CN206027207U (en) 2016-06-23 2016-06-23 Coronary heart disease treatment filter

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201620625224.6U CN206027207U (en) 2016-06-23 2016-06-23 Coronary heart disease treatment filter

Publications (1)

Publication Number Publication Date
CN206027207U true CN206027207U (en) 2017-03-22

Family

ID=58312984

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201620625224.6U Expired - Fee Related CN206027207U (en) 2016-06-23 2016-06-23 Coronary heart disease treatment filter

Country Status (1)

Country Link
CN (1) CN206027207U (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537205A (en) * 2016-06-23 2018-01-05 江苏博发生物科技有限公司 Coronary heart disease treatment filter

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107537205A (en) * 2016-06-23 2018-01-05 江苏博发生物科技有限公司 Coronary heart disease treatment filter

Similar Documents

Publication Publication Date Title
US11471577B2 (en) System for providing an integrated arterial filter into an oxygenator, minimizing added priming volume
CN104800902A (en) Extracorporeal circulation life supporting device for treating and curing multiple organ failure
CN207122983U (en) A kind of anti-infection isolating device of Respiratory Medicine
CN205073378U (en) Get rid of bilirubin blood purifying filter
CN203507201U (en) Separating type hemodialysis absorber
CN115192807B (en) Oxygenator and external membrane pulmonary oxygenation device
CN206027207U (en) Coronary heart disease treatment filter
CN207137088U (en) A kind of multipurpose blood purification
CN105555332B (en) The filter plant of venous blood
EP2042221A1 (en) Filter for body fluids
CN205885876U (en) Hyperlipidemia treatment filter
CN213554272U (en) Filter for plasma filtration treatment
CN205885875U (en) Eye ground artery blocks treatment filter
CN205667666U (en) There is the filter for infusion of dual channel
CN201040115Y (en) Thin membrane type white blood cell filter
CN205759038U (en) A kind of pump-free type ECMO
CN107537205A (en) Coronary heart disease treatment filter
CN104984427B (en) A kind of hollow fiber membrane oxygenator with ultrafiltration apparatus
CN205796973U (en) Hepatitis b virus filter
CN206081172U (en) Blood purifies venous pipeline during EMCO
CN206120585U (en) Portable external life support system
CN203417361U (en) Square plasma storage pool special for plasma exchange adsorption filtration treatment
CN205268705U (en) Uremia patient uses hemodialysis ware
CN107875468A (en) A kind of blood nanofilter
CN212214764U (en) Medical filter

Legal Events

Date Code Title Description
C14 Grant of patent or utility model
GR01 Patent grant
CB03 Change of inventor or designer information

Inventor after: Jiang Nongfa

Inventor after: Wang Long

Inventor after: Shao Jianwei

Inventor before: Huang Heping

CB03 Change of inventor or designer information
TR01 Transfer of patent right

Effective date of registration: 20171211

Address after: 214200 Huaxing Road, Yicheng street, Yixing City, Wuxi, Jiangsu Province, No. 108

Patentee after: Hang Yuxian

Address before: 214200 Huaxing Road, Yicheng street, Yixing City, Wuxi, Jiangsu Province, No. 108

Patentee before: JIANGSU BOFA BIOTECHNOLOGY CO., LTD.

TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20180816

Address after: 214213 101, room 2, Yixing Photoelectric Industrial Park, 10 Xing Li Road, Yixing economic and Technological Development Zone, Jiangsu, China

Patentee after: Yixing Bernard Investment Co., Ltd.

Address before: 214200 No. 108 Huaxing Road, Yicheng street, Yixing, Wuxi, Jiangsu

Patentee before: Hang Yuxian

TR01 Transfer of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170322

Termination date: 20210623

CF01 Termination of patent right due to non-payment of annual fee